Gerald Crans

3.0k total citations
35 papers, 2.2k citations indexed

About

Gerald Crans is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Gerald Crans has authored 35 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Orthopedics and Sports Medicine, 11 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Gerald Crans's work include Bone health and osteoporosis research (14 papers), Bone Metabolism and Diseases (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Gerald Crans is often cited by papers focused on Bone health and osteoporosis research (14 papers), Bone Metabolism and Diseases (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Gerald Crans collaborates with scholars based in United States, Canada and France. Gerald Crans's co-authors include Harry K. Genant, Imre Pávó, Bruce Ettinger, Ethel S. Siris, M. Wong, Jonathan D. Adachi, John H. Krege, P. D. Delmas, John L. Stock and Pierre D. Delmas and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Gerald Crans

32 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald Crans United States	20	1.4k	825	634	481	295	35	2.2k
Kristine D. Harper United States	23	1.6k 1.2×	1.0k 1.2×	913 1.4×	683 1.4×	1.1k 3.6×	37	3.1k
Ho Yeon Chung South Korea	22	476 0.3×	422 0.5×	518 0.8×	258 0.5×	177 0.6×	73	1.8k
Rebeca Reyes‐García Spain	18	472 0.3×	311 0.4×	475 0.7×	139 0.3×	136 0.5×	84	1.3k
Anthony Sebba United States	19	387 0.3×	493 0.6×	346 0.5×	117 0.2×	59 0.2×	37	2.0k
Rachel Fleming United States	19	109 0.1×	314 0.4×	495 0.8×	206 0.4×	76 0.3×	41	1.8k
Gül Bahtiyar United States	13	243 0.2×	127 0.2×	317 0.5×	113 0.2×	78 0.3×	42	1.2k
Leonid Katz United States	12	551 0.4×	622 0.8×	773 1.2×	413 0.9×	169 0.6×	18	1.7k
Hiroyuki Yamashita Japan	29	101 0.1×	408 0.5×	253 0.4×	1.1k 2.3×	299 1.0×	128	2.2k
Ling Lan China	19	78 0.1×	256 0.3×	400 0.6×	268 0.6×	113 0.4×	77	1.2k
Ling Oei Netherlands	23	1.1k 0.8×	467 0.6×	599 0.9×	431 0.9×	203 0.7×	44	1.8k

Countries citing papers authored by Gerald Crans

Since Specialization

Citations

This map shows the geographic impact of Gerald Crans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Crans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Crans more than expected).

Fields of papers citing papers by Gerald Crans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Crans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Crans. The network helps show where Gerald Crans may publish in the future.

Co-authorship network of co-authors of Gerald Crans

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Crans. A scholar is included among the top collaborators of Gerald Crans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Crans. Gerald Crans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hibi∥, Toshifumi, Satoshi Motoya, Tadakazu Hisamatsu, et al.. (2022). Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial. Intestinal Research. 21(1). 110–125. 13 indexed citations

Trivedi, Palak, Andrew J. Muir, Cynthia Levy, et al.. (2020). Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology. 19(6). 1248–1257. 34 indexed citations

Buti, Marı́a, David Wong, Edward Gane, et al.. (2019). Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials. The Lancet. Gastroenterology & hepatology. 4(4). 296–304. 22 indexed citations

Picozzi, Vincent J., Flavio G. Rocha, Scott Helton, et al.. (2016). Randomized, open-label trial of gemcitabine/nab-paclitaxel (G/NP) ±FG-3019 as neoadjuvant chemotherapy in locally advanced, unresectable pancreatic cancer (LAPC).. Journal of Clinical Oncology. 34(4_suppl). 457–457. 2 indexed citations

Cedarbaum, Jesse M., Gerald Crans, & Michael Grundman. (2010). Seeing with new eyes: Finding a path to early intervention trials in Alzheimer's disease. The journal of nutrition health & aging. 14(4). 306–309. 8 indexed citations

Fuerst, Thomas, Chun‐Ying Wu, Harry K. Genant, et al.. (2008). Evaluation of vertebral fracture assessment by dual X-ray absorptiometry in a multicenter setting. Osteoporosis International. 20(7). 1199–1205. 76 indexed citations

Crans, Gerald & Jonathan J. Shuster. (2008). How conservative is Fisher's exact test? A quantitative evaluation of the two‐sample comparative binomial trial. Statistics in Medicine. 27(18). 3598–3611. 33 indexed citations

Uusi‐Rasi, Kirsti, Thomas Beck, Maithili M. Daphtary, et al.. (2006). Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial. Osteoporosis International. 17(4). 575–586. 45 indexed citations

Genant, Harry K., Ethel S. Siris, Gerald Crans, D. Desaiah, & John H. Krege. (2005). Reduction in vertebral fracture risk in teriparatide-treated postmenopausal women as assessed by spinal deformity index. Bone. 37(2). 170–174. 18 indexed citations

10.

Crans, Gerald, Harry K. Genant, & John H. Krege. (2005). Prognostic utility of a semiquantitative spinal deformity index. Bone. 37(2). 175–179. 102 indexed citations

11.

Gallagher, John C., Harry K. Genant, Gerald Crans, Socorro J. Vargas, & John H. Krege. (2005). Teriparatide Reduces the Fracture Risk Associated with Increasing Number and Severity of Osteoporotic Fractures. The Journal of Clinical Endocrinology & Metabolism. 90(3). 1583–1587. 101 indexed citations

12.

Seeman, Ego, et al.. (2005). Anti-vertebral fracture efficacy of raloxifene: a meta-analysis. Osteoporosis International. 17(2). 313–316. 70 indexed citations

13.

Jirecek, Stefan, et al.. (2004). Raloxifene prevents the growth of uterine leiomyomas in premenopausal women. Fertility and Sterility. 81(1). 132–136. 47 indexed citations

14.

Crans, Gerald, Stuart L. Silverman, Harry K. Genant, Emmett V. Glass, & John H. Krege. (2004). Association of severe vertebral fractures with reduced quality of life: Reduction in the incidence of severe vertebral fractures by teriparatide. Arthritis & Rheumatism. 50(12). 4028–4034. 39 indexed citations

15.

Weinstein, Robert S., A. M. Parfitt, Robert Marcus, et al.. (2003). Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women. Osteoporosis International. 14(10). 814–822. 57 indexed citations

16.

Delmas, P. D., Harry K. Genant, Gerald Crans, et al.. (2003). Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone. 33(4). 522–532. 406 indexed citations

17.

Jolly, E., Nina H. Bjarnason, Patrick Neven, et al.. (2003). Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years. Menopause The Journal of The North American Menopause Society. 10(4). 337–344. 85 indexed citations

18.

Kung, Annie W.C., Hsiang‐Tai Chao, Ko-En Huang, et al.. (2003). Efficacy and Safety of Raloxifene 60 Milligrams/Day in Postmenopausal Asian Women. The Journal of Clinical Endocrinology & Metabolism. 88(7). 3130–3136. 30 indexed citations

19.

Siris, Ethel S., Jonathan D. Adachi, Ying Lü, et al.. (2002). Effects of Raloxifene on Fracture Severity in Postmenopausal Women with Osteoporosis: Results from the MORE Study. Osteoporosis International. 13(11). 907–913. 67 indexed citations

20.

Roth, Jeffrey, Gerald Crans, Randy L. Carter, Mario Ariet, & Michael B. Resnick. (1999). Effect of High School Course-Taking and Grades on Passing a College Placement Test.. The High School journal. 1999(1). 72–87. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact